Abstract
The study aimed to evaluate the metabolic and inflammatory effects of short-term treatments (10 days) with metformin (MET) on the NAFLD caused by a high-fat diet (HFD) in C57BL/6 mice. After the treatment, histological liver slices were obtained, hepatocytes and macrophages were extracted and cultured with phosphate buffered saline, LPS (2.5 µg/mL) and MET (1 µM) for 24 h. Cytokine levels were determined by ELISA. NAFLD caused by the HFD was partially reduced by MET. The lipid accumulation induced by the HFD was not associated with liver inflammation; however, MET seemed to promote pro-inflammatory effects in liver, since it increased hepatic concentration of IL-1β, TNF-α, IL-6, MCP-1 and IFN-γ. Similarly, MET increased the concentration of IL-1β, IL-6 in hepatocyte cultures. However, in macrophages culture, MET lowered levels of IL-1β, IL-6 and TNF-α stimulated by LPS. Overall, MET reduced liver NAFLD but promoted hepatocyte increase in pro-inflammatory cytokines, thus, leading to liver inflammation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adams LA, Angulo P, Lindor KD (2005) Nonalcoholic fatty liver disease. CMAJ 172:899–905. https://doi.org/10.1503/cmaj.045232
Bergmeyer H, Bernet E (1974) Determination of glucose with glucoseoxidase and peroxidase. In: Bergmeyer H (ed) Methods of enzymatic analysis. Academic Press, New York, pp 1205–1215
Berlanga A, Guiu-Jurado E, Porras JA, Auguet T (2014) Molecular pathways in non-alcoholic fatty liver disease. Clin Exp Gastroenterol 7:221–239. https://doi.org/10.2147/CEG.S62831
Bi Y et al (2013) The beneficial effect of metformin on beta-cell function in non-obese Chinese subjects with newly diagnosed type 2 diabetes. Diabetes Metab Res Rev 29:664–672. https://doi.org/10.1002/dmrr.2443
Bogachus LD, Turcotte LP (2010) Genetic downregulation of AMPK-alpha isoforms uncovers the mechanism by which metformin decreases FA uptake and oxidation in skeletal muscle cells. Am J Physiol Cell Physiol 299:C1549–1561. https://doi.org/10.1152/ajpcell.00279.2010
Brestoff JR, Artis D (2015) Immune regulation of metabolic homeostasis in health and disease. Cell 161:146–160. https://doi.org/10.1016/j.cell.2015.02.022
Casas R, Sacanella E, Estruch R (2014) The immune protective effect of the mediterranean diet against chronic low-grade inflammatory diseases. Endocr Metab Immune Disord Drug Targets 14:245–254
Challiss RA, Espinal J, Newsholme EA (1983) Insulin sensitivity of rates of glycolysis and glycogen synthesis in soleus, stripped soleus, epitrochlearis, and hemi-diaphragm muscles isolated from sedentary rats. Biosci Rep 3:675–679
Chen M, Zhang J, Liu S, Zhou Z (2015) Effects of metformin on the polarization and Notch 1 expression of RAW264.7 macrophages. Zhonghua Yi Xue Za Zhi 95:1258–1261
Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159. https://doi.org/10.1006/abio.1987.9999
de Morais H, Cassola P, Moreira CC, Bôas SK, Borba-Murad GR, Bazotte RB, de Souza HM (2012) Decreased response to cAMP in the glucose and glycogen catabolism in perfused livers of Walker-256 tumor-bearing rats. Mol Cell Biochem 368:9–16. https://doi.org/10.1007/s11010-012-1337-4
Edwards M, Houseman L, Phillips IR, Shephard EA (2013) Isolation of mouse hepatocytes. Methods Mol Biol 987:283–293. https://doi.org/10.1007/978-1-62703-321-3_24
Espinal J, Challiss RA, Newsholme EA (1983) Effect of adenosine deaminase and an adenosine analogue on insulin sensitivity in soleus muscle of the rat. FEBS Lett 158:103–106
Fader KA et al (2015) 2,3,7,8-Tetrachlorodibenzo-p-Dioxin alters lipid metabolism and depletes immune cell populations in the Jejunum of C57BL/6 Mice. Toxicol Sci 148:567–580. https://doi.org/10.1093/toxsci/kfv206
Flannery C, Dufour S, Rabol R, Shulman GI, Petersen KF (2012) Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly. Diabetes 61:2711–2717. https://doi.org/10.2337/db12-0206
Foretz M, Viollet B (2011) Regulation of hepatic metabolism by AMPK. J Hepatol 54:827–829. https://doi.org/10.1016/j.jhep.2010.09.014
Hirabara SM et al (2006) Acute effect of fatty acids on metabolism and mitochondrial coupling in skeletal muscle. Biochim Biophys Acta 1757:57–66. https://doi.org/10.1016/j.bbabio.2005.11.007
Kelly B, Tannahill GM, Murphy MP, O’Neill LA (2015) Metformin inhibits the production of reactive oxygen species from NADH: ubiquinone oxidoreductase to limit induction of interleukin-1beta (IL-1beta) and boosts Interleukin-10 (IL-10) in Lipopolysaccharide (LPS)-activated Macrophages. J Biol Chem 290:20348–20359. https://doi.org/10.1074/jbc.M115.662114
Kim J, Kwak HJ, Cha JY, Jeong YS, Rhee SD, Kim KR, Cheon HG (2014) Metformin suppresses lipopolysaccharide (LPS)-induced inflammatory response in murine macrophages via activating transcription factor-3 (ATF-3) induction. J Biol Chem 289:23246–23255. https://doi.org/10.1074/jbc.M114.577908
Kitajima Y et al (2013) Severity of non-alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle. J Gastroenterol Hepatol 28:1507–1514. https://doi.org/10.1111/jgh.12227
Kitzmann M, Lantier L, Hebrard S, Mercier J, Foretz M, Aguer C (2011) Abnormal metabolism flexibility in response to high palmitate concentrations in myotubes derived from obese type 2 diabetic patients. Biochim Biophys Acta 1812:423–430. https://doi.org/10.1016/j.bbadis.2010.12.007
Koh SJ, Kim JM, Kim IK, Ko SH, Kim JS (2014) Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer. J Gastroenterol Hepatol 29:502–510
Leighton B, Budohoski L, Lozeman FJ, Challiss RA, Newsholme EA (1985) The effect of prostaglandins E1, E2 and F2 alpha and indomethacin on the sensitivity of glycolysis and glycogen synthesis to insulin in stripped soleus muscles of the rat. Biochem J 227:337–340
Liu C et al (2016) Targeting arginase-II protects mice from high-fat-diet-induced hepatic steatosis through suppression of macrophage inflammation. Sci Rep 6:20405. https://doi.org/10.1038/srep20405
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408. https://doi.org/10.1006/meth.2001.1262
Love-Osborne KA, Nadeau KJ, Sheeder J, Fenton LZ, Zeitler P (2008) Presence of the metabolic syndrome in obese adolescents predicts impaired glucose tolerance and nonalcoholic fatty liver disease. J Adolesc Health 42:543–548. https://doi.org/10.1016/j.jadohealth.2007.11.136
McCullough AJ (2004) The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 8:521–533. https://doi.org/10.1016/j.cld.2004.04.004
McNelis JC, Olefsky JM (2014) Macrophages, immunity, and metabolic disease. Immunity 41:36–48. https://doi.org/10.1016/j.immuni.2014.05.010
Mikami Y et al (2014) Macrophages and dendritic cells emerge in the liver during intestinal inflammation and predispose the liver to inflammation. PLoS ONE 9:e84619. https://doi.org/10.1371/journal.pone.0084619
Moon JS, Yoon JS, Won KC, Lee HW (2013) The role of skeletal muscle in development of nonalcoholic Fatty liver disease. Diabetes Metab J 37:278–285. https://doi.org/10.4093/dmj.2013.37.4.278
Nasri H, Rafieian-Kopaei M (2014) Metformin: current knowledge. J Res Med Sci 19:658–664
Nati M, Haddad D, Birkenfeld AL, Koch CA, Chavakis T, Chatzigeorgiou A (2016) The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH). Rev Endocr Metab Disord. https://doi.org/10.1007/s11154-016-9339-2
Patane G, Piro S, Rabuazzo AM, Anello M, Vigneri R, Purrello F (2000) Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells. Diabetes 49:735–740
Reeves PG, Nielsen FH, Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939–1951
Said A, Akhter A (2017) Meta-analysis of randomized controlled trials of pharmacologic agents in non-alcoholic steatohepatitis. Ann Hepatol 16:538–547. https://doi.org/10.5604/01.3001.0010.0284
Saisho Y (2015) Metformin and inflammation: its potential beyond glucose-lowering effect. Endocr Metab Immune Disord Drug Targets 15:196–205
Salminen A, Hyttinen JM, Kaarniranta K (2011) AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan. J Mol Med (Berl) 89:667–676. https://doi.org/10.1007/s00109-011-0748-0
Souza-Mello V, Gregorio BM, Cardoso-de-Lemos FS, de Carvalho L, Aguila MB, Mandarim-de-Lacerda CA (2010) Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet. Clin Sci (Lond) 119:239–250. https://doi.org/10.1042/CS20100061
Spruss A, Kanuri G, Stahl C, Bischoff SC, Bergheim I (2012) Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function. Lab Invest 92:1020–1032. https://doi.org/10.1038/labinvest.2012.75
Teixeira AA et al (2016) Aerobic exercise modulates the free fatty acids and inflammatory response during obesity and cancer cachexia. Crit Rev Eukaryot Gene Expr 26:187–198. https://doi.org/10.1615/CritRevEukaryotGeneExpr.2016016490
Tiniakos DG, Vos MB, Brunt EM (2010) Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 5:145–171. https://doi.org/10.1146/annurev-pathol-121808-102132
VanSaun MN, Lee IK, Washington MK, Matrisian L, Gorden DL (2009) High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorectal metastases and promotes primary dysplasia in a murine model. Am J Pathol 175(1):355–364
Vasamsetti SB, Karnewar S, Kanugula AK, Thatipalli AR, Kumar JM, Kotamraju S (2015) Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation: potential role in atherosclerosis. Diabetes 64:2028–2041. https://doi.org/10.2337/db14-1225
Viollet B et al (2009) Targeting the AMPK pathway for the treatment of Type 2 diabetes. Front Biosci (Landmark Ed) 14:3380–3400
Wan X, Xu C, Yu C, Li Y (2016) Role of NLRP3 inflammasome in the progression of NAFLD to NASH. Can J Gastroenterol Hepatol 2016:6489012. https://doi.org/10.1155/2016/6489012
Wang C et al (2014) Metformin suppresses lipid accumulation in skeletal muscle by promoting fatty acid oxidation. Clin Lab 60:887–896
Woo SL et al (2014) Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity. PLoS ONE 9:e91111. https://doi.org/10.1371/journal.pone.0091111
Xu L, Kitade H, Ni Y, Ota T (2015a) Roles of chemokines and chemokine receptors in obesity-associated insulin resistance and nonalcoholic fatty liver disease. Biomolecules 5:1563–1579. https://doi.org/10.3390/biom5031563
Xu W et al (2015b) Metformin ameliorates the proinflammatory state in patients with carotid artery atherosclerosis through sirtuin 1 induction. Transl Res 166:451–458. https://doi.org/10.1016/j.trsl.2015.06.002
Yadav UC, Ramana KV (2013) Regulation of NF-kappaB-induced inflammatory signaling by lipid peroxidation-derived aldehydes. Oxid Med Cell Longev 2013:690545. https://doi.org/10.1155/2013/690545
Acknowledgements
To the funding sources, Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP, Brazil) process number 2013/09367-4, 2015/16777-0 and 2016/01409-8, and the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, Brazil).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interests regarding the publication of this paper.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
de Souza Teixeira, A.A., Souza, C.O., Biondo, L.A. et al. Short-term treatment with metformin reduces hepatic lipid accumulation but induces liver inflammation in obese mice. Inflammopharmacol 26, 1103–1115 (2018). https://doi.org/10.1007/s10787-018-0443-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-018-0443-7